Watch Ticker

Viatris Inc. Common Stock

Go to Viatris Inc. Common Stock Website

$8.94

0.13 (1.48%)

Live

Previous Close

$8.94

Day Range

$8.8 - $8.99

Previous Day Range

$8.625 - $8.87

Market Cap

$10.3 billion USD

Day Vol.

6.6 million

Previous Day Vol.

6.7 million

Currency

USD

Primary Exchange

Nasdaq

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining f...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Vandana Singh - Goldman Sachs Bullish On Branded Drug Upside At Teva: What About Viatris?

Goldman Sachs initiated coverage on several generic pharmaceutical stocks, highlighting Teva's branded drug growth and biosimilar pipeline as positives, while expressing neutrality on Viatris due to uncertainty around its core business. The firm also initiated Amneal with a Buy rating, citing its strong product pipeline and ability to offset price erosion.

Related tickers: TEVA, VTRS, AMRX.

Read Full Article

Bronstein, Gewirtz & Grossman, Llc - VTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

A class action lawsuit has been filed against Viatris Inc. (VTRS) for allegedly providing investors with material information concerning the failed inspection of its Indore, India facility and misrepresenting the impact of the FDA's warning letter.

Related tickers: VTRS.

Read Full Article

Trending Tickers

Please sign in to view